Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate Grant uri icon

Overview

date/time interval

  • September 1, 2017 - August 31, 2024

sponsor award ID

  • 17CHAL05

Affiliation